rs371923295
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_001080.3(ALDH5A1):c.62G>A(p.Gly21Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000563 in 1,349,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001080.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 151964Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000220 AC: 15AN: 68048Hom.: 0 AF XY: 0.000252 AC XY: 10AN XY: 39662
GnomAD4 exome AF: 0.0000434 AC: 52AN: 1197354Hom.: 0 Cov.: 31 AF XY: 0.0000566 AC XY: 33AN XY: 582738
GnomAD4 genome AF: 0.000158 AC: 24AN: 152072Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74346
ClinVar
Submissions by phenotype
Succinate-semialdehyde dehydrogenase deficiency Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 31, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at